• Working in the present, thinking the future

  • Health, our greatest asset value

  • Pharmacovigilance

  • Patient Centricity

We provide drugs with a high added value for health care and treatments for high complexity diseases, for both overall patients and the medical and scientific community

Our products

are mainly addressed to be used in hematologic, oncologic, urologic, neurologic and nephrologic pathologies as well as rare diseases

News

(Español) NUEVO LANZAMIENTO IBRULEU® ibrutinib

04/06/2021

(Español) Desde Bioprofarma Bagó nos complace presentar nuestro nuevo producto IBRULEU® ibrutinib

(Español) Ateneo Hospital Pirovano

28/05/2021

(Español) Nos complace compartirles la disertación de la Dra. Ana Acosta en el ateneo del Hospital Pirovano

(Español) NUEVO LANZAMIENTO ORNATE® eltrombopag

24/05/2021

(Español) Desde Bioprofarma Bagó nos complace presentar nuestro nuevo producto, ORNATE® eltrombopag, ampliando la línea de hematología.

Bioprofarma Bagó worldwide